Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 1 Characteristics of participating doctors by country and medical specialty

From: Variation in the psychosocial determinants of the intention to prescribe hormone therapy prior to the release of the Women's Health Initiative trial: a survey of general practitioners and gynaecologists in France and Quebec

 

Quebec

France

 

General Practitioners n = 334 (%)

Gynaecologists n = 130 (%)

General Practitioners n = 425 (%)

Gynaecologists n = 586 (%)

Women

140 (42%)

35 (27%)

98 (23%)

316 (54%)

Age (years)

41.5 ± 8.6

47.4 ± 10.8

43.7 ± 7.6

45.4 ± 8.3

Number of years in practice

    

   <8 years

82 (25%)

31 (24%)

109 (26%)

107 (18%)

   9 – 15 years

92 (27%)

20 (15%)

116 (27%)

236 (40%)

   16 – 21 years

90 (27%)

28 (21%)

125 (29%)

124 (21%)

   >22 years

70 (21%)

51 (39%)

75 (18%)

119 (21%)

Rural place of practice

88 (27%)

8 (6%)

162 (38%)

55 (9%)

Number of patients/day*

    

   <10

19 (6%)

6 (5%)

15 (4%)

42 (7%)

   10 – 20

95 (29%)

20 (15%)

170 (40%)

299 (52%)

   20 – 40

191 (58%)

83 (64%)

221 (53%)

224 (39%)

   >40

24 (7%)

21 (16%)

14 (3%)

15 (2%)

% of menopausal patients in clientele

29.1 ± 25.0

56.0 ± 24.8

21.4 ± 20.2

50.5 ± 27.3

% who use menopausal diagnostic criteria**

    

   Symptoms

118 (35%)

64 (49%)

174 (41%)

290 (49%)

   Hormonal dosages

101 (30%)

23 (18%)

126 (30%)

173 (30%)

   Cessation of menses

227 (68%)

78 (60%)

268 (63%)

328 (56%)

Discuss HT with all menopausal patients

122 (38%)

66 (51%)

101 (24%)

355 (61%)

Examinations performed**

    

   Cytology (PAP smear)

292 (87%)

129 (87%)

363 (85%)

519 (89%)

   Mammography

288 (86%)

120 (92%)

381 (90%)

578 (99%)

   Breast examination

306 (92%)

127 (98%)

377 (89%)

580 (99%)

   Hormonal dosages

113 (34%)

17 (13%)

139 (33%)

152 (26%)

   Lipid profile

245 (73%)

59 (45%)

349 (82%)

387 (66%)

   Endometrial biopsy

3 (1%)

16 (12%)

11 (3%)

40 (7%)

   Bone mass density

30 (9%)

16 (12%)

84 (20%)

77 (13%)

   Vaginal ultrasound

1 (0,3%)

4 (3%)

21 (5%)

158 (27%)

   Thyroid gland examination

251 (75%)

61 (47%)

187 (44%)

156 (27%)

   Pelvic examination

270 (81%)

126 (97%)

307 (72%)

569 (97%)

   Speculum

272 (81%)

126 (97%)

276 (65%)

570 (97%)

   Blood pressure

308 (92%)

119 (92%)

391 (92%)

569 (97%)

   Cardiac auscultation

285 (85%)

29 (22%)

363 (85%)

148 (25%)

   Weight

257 (77%)

58 (45%)

341 (80%)

505 (86%)

HT prescription patterns > 70% of cases

106 (34%)

86 (67%)

36 (9%)

309 (55%)

  1. * Total number of doctors within the subgroup might differ from total number of participating doctors because of missing data.
  2. ** Categories are not mutually exclusive.
Back to article page

BMC Medical Informatics and Decision Making

ISSN: 1472-6947

Contact us